Gerald E Quirk's Net Worth
$117 Thousand
Who is Gerald E Quirk?
Gerald E Quirk does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syros Pharmaceuticals, Inc., INFINITY PHARMACEUTICALS, INC., and Tokai Pharmaceuticals Inc.
SEC CIK
Gerald E Quirk's CIK is 0001479603
Past Insider Trading and Trends
2015 was Gerald E Quirk's most active year for acquiring shares with 2 total transactions. Gerald E Quirk's most active month to acquire stocks was the month of January. 2023 was Gerald E Quirk's most active year for disposing of shares, totalling 2 transactions. Gerald E Quirk's most active month to dispose stocks was the month of February. 2015 saw Gerald E Quirk paying a total of $0.00 for 276,605 shares, this is the most they've acquired in one year. In 2024 Gerald E Quirk cashed out on 29,546 shares for a total of $39,387.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Chief Legal & Compliance Offic
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.59% | 15.45K |
$5.59 | -$39,387.14 | 39.76K |
Mar 27 - Mar 28
| |||
Form 4
| +179.34% | 15.6K |
$2.10 | -$14,483.70 | 24.3K |
Oct 11 - Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
∞
| 87K |
—
|
—
| 87K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tokai Pharmaceuticals Inc (ELDN) Snapshot price: $2.664
General Counsel, Executive VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||